-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OTC1vJXQR0lM0Oj65S98aYLuVRCIO3Yb93zw9e0zAB5jAGoJiIbl2X/XJCnqX4pN c4gFJJ3PsJq/fJibc6MkTQ== 0001104659-07-071788.txt : 20070927 0001104659-07-071788.hdr.sgml : 20070927 20070927173948 ACCESSION NUMBER: 0001104659-07-071788 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070925 FILED AS OF DATE: 20070927 DATE AS OF CHANGE: 20070927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEWIS JEROME M CENTRAL INDEX KEY: 0001225855 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14732 FILM NUMBER: 071140205 BUSINESS ADDRESS: BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: C/O ADVANCED MAGNETICS INC STREET 2: 61 MOONEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02138 4 1 a4.xml 4 X0202 4 2007-09-25 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001225855 LEWIS JEROME M C/O AMAG PHARMACEUTICALS, INC. 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 0 1 0 0 VP of Scientific Operations Common Stock 19994 D Employee Stock Options (Right to Buy) 54.97 2007-09-25 4 M 0 17000 A 2017-09-25 Common Stock 17000 17000 D Previously, Mr. Lewis reported in error that he owned 19,945 shares. Mr. Lewis owns such shares jointly with his spouse. Grant of stock option pursuant to the AMAG Pharmaceuticals, Inc. Amended and Restated 2000 Stock Plan. This option is exercisable in four equal annual installments. The first installment will vest on September 25, 2008, the first anniversary of the grant, and the next three installments will vest on September 25, 2009, September 25, 2010, and September 25, 2011. The exercise price is reported in column 2. /s/ Joseph L. Farmer, attorney-in-fact 2007-09-27 -----END PRIVACY-ENHANCED MESSAGE-----